Navigation Links
Mindray Announces Second Quarter 2012 Financial Results
Date:8/6/2012

SHENZHEN, China, Aug. 6, 2012 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2012. 

Highlights for Second Quarter 2012

  • Net revenues were $267.8 million, an increase of 23.3% over the second quarter of 2011.
  • Robust China sales growth of 27.1% to $115.3 million year-over-year, primarily driven by regular sales.
  • Strong international sales of $152.5 million, representing an increase of 20.5% from the same period last year. Emerging markets[1] and developed markets[2] achieved good sales growth of 21.1% and 19.7% year-over-year, respectively.
  • Non-GAAP gross margin was 57.8%, an improvement of 2.3% sequentially.
  • Non-GAAP net income was $59.5 million, a 19.4% increase over the second quarter of 2011.
  • Net operating cash generated during the quarter was $61.4 million, up a significant 81.6% compared to the same period last year.
  • Reagent revenues growth accelerated, contributing 34.4% to the in-vitro diagnostic business this quarter, compared to 28.4% in the same period last year and 31.5% in the prior quarter.
  • Mindray introduced five new products in the first half of 2012, including the latest high speed biochemistry analyzer, the BS-2000, a clinical biochemistry analyzer, the BS-480, an updated auto hematology analyzer, the BC-5390, a fully automatic urinary sediment analyzer, the EH-2050B Plus, and a new portable diagnostic color ultrasound system, the Z6.
  • In July, Mindray completed the acquisition of a controlling stake in Wuhan Dragonbio Surgical Implant Co., Ltd., a domestic medical orthopedic products provider.
  • "Despite the challenging environments in various international
    '/>"/>

    SOURCE Mindray Medical International Limited
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Mindray to Report Second Quarter 2012 Financial Results on August 6, 2012
    2. Mindray Medical Completes Acquisition of Dragonbios Orthopedics Business
    3. Mindray Medical to Present at AACC Clinical Lab Expo 2012
    4. Mindray Announces First Quarter 2012 Financial Results
    5. Mindray Medical to Acquire Controlling Stake in Hangzhou Optcla Medical Instrument
    6. Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
    7. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
    8. Isis Pharmaceuticals Announces Proposed Offering of $175 Million of Convertible Senior Notes
    9. Fuse Science Announces Landmark Licensing Agreement with Industry Leader Macular Health
    10. Bausch + Lomb Announces Extension of Early Tender Date for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
    11. TWi Pharmaceuticals Announces Positive Phase IIb Clinical Trial Results of AC-201 in Patients with Type 2 Diabetes.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)...  Bio-Techne Corporation (NASDAQ: TECH ) announced today ... the new Simple Plex platform through its Proteins Platform ... re-branding of the previously acquired CyPlex instrument platform from ... transformative immunoassay technology which integrates an innovatively designed microfluidic ...
    (Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and Markets ... of the "Infectious Disease Diagnostics Market by Product, ... report to their offering. , The ... CAGR of 7.9% to reach $18,156.2 million by 2019 ...
    (Date:1/22/2015)... The Parenteral Drug Association (PDA) today announced the launch ... Pharmaceutical Manufacturing,s Future. The Manufacturing Science ... , Highlight the ongoing focus PDA has on pharmaceutical and ... filling known gaps in current manufacturing science as well as ...
    Breaking Medicine Technology:Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3PDA Launches Manufacturing Science Program(SM) 2PDA Launches Manufacturing Science Program(SM) 3
    ... MedImmune today announced,that it has initiated a Phase ... healthy children one month to 12 months of age ... is,the most common respiratory infection in infants and can ... is a serious respiratory disease that can have significant ...
    ... Meeting -, - Conference call to be hosted ... BRANFORD, Conn., Nov. 3 CuraGen Corporation,(Nasdaq: CRGN ... II,trial of CR011-vcMMAE, an antibody-drug conjugate that targets GPNMB, ... Stage IV melanoma.,Dr. Patrick Hwu, Co-Principal Investigator, and Professor ...
    Cached Medicine Technology:MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7
    (Date:1/22/2015)... Illinois (PRWEB) January 22, 2015 Deer Path ... will host a Valentine’s Day Happy Hour from 3 p.m. to ... at 12500 Regency Parkway in Huntley, Illinois, serves adults with physical ... Hour event will include Valentine's Day treats, games and sweetheart-themed karaoke. ...
    (Date:1/22/2015)... 22, 2015 The City of West Hollywood hosted ... to commemorate the 42nd anniversary of the Supreme Court decision Roe ... been 42 years since the Roe vs. Wade decision and the ... present as ever,” said City of West Hollywood Councilmember Abbe Land. ...
    (Date:1/22/2015)... January 23, 2015 VogueQueen is a seasoned ... prices and many designers are thrilled to have it lead ... announces its new collection of prom dresses for the global ... drive the strategic vision and he focuses on continuing the ...
    (Date:1/22/2015)... January 23, 2015 AngelWeddingDress, the premier ... 2015 maternity wedding dresses. View website of ... looking for maternity wedding dresses online for a bridal ... with high quality for them. Its maternity wedding dresses ...
    (Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
    Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
    ... the Florida-based processor of orthopedic, dental, hernia and other biologic implants, ... of RTI’s fresh-stored osteochondral (OC) allografts since its first implant in ... implants to repair cartilage damage, reducing their pain and returning them ... ...
    ... seeking to improve scientists, understanding of breast cancer, including why ... getting underway in 44 counties in North Carolina. , The ... Carolina state senator who died of breast cancer last year, ... the University of North Carolina at Chapel Hill. , The ...
    ... The College of,American Pathologists, a medical society serving ... throughout the world, today announced,that Charles Roussel has ... daily operations of the College and reporting to ... in transformational change, as well,as a passion for ...
    ... out for,the soccer team or training for a dance ... greater than adults. After all, they need,nutrition for growth ... from the foods they consume., Nutritious snacks that ... to,helping young athletes perform at their best. Portable snacks ...
    ... today announced it is,hosting a web seminar to ... requirements and leverage the same technology to improve,overall ... and recent,government enforcements to ensure security and data ... a top priority for many healthcare,organizations and this ...
    ... grow around nerves in a rare genetic disease need cooperation ... reports a team of scientists, including researchers from UT Southwestern ... the immune cells not the tumor greatly reduced ... A clinical trial of the treatment in humans has begun. ...
    Cached Medicine News:Health News: RTI Biologics Sees Expanded Surgeon User Base of Fresh OC Allografts 2Health News: RTI Biologics Sees Expanded Surgeon User Base of Fresh OC Allografts 3Health News: RTI Biologics Sees Expanded Surgeon User Base of Fresh OC Allografts 4Health News:UNC Lineberger launches 44-county study of breast cancer in black women 2Health News:UNC Lineberger launches 44-county study of breast cancer in black women 3Health News:College of American Pathologists Selects Charles Roussel as Its New Executive Vice President 2Health News:Fueling Kids for Sports 2Health News:nCircle Announces Free Web Seminar - 'Automating HIPAA Compliance with Security & Configuration Auditing' 2Health News:Cancer requires support from immune system to develop, UT Southwestern researchers report 2Health News:Cancer requires support from immune system to develop, UT Southwestern researchers report 3
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: